Literature DB >> 566330

Genitourinary malignancy and pseudohyperparathyroidism.

J B Metcalfe, T C Carey, J M Barry.   

Abstract

Genitourinary tumors account for half of all documented cases of pseudohyperparathyroidism. The treatment of hypercalcemia is directed toward immediate correction of the electrolyte imbalance and long-term control. These goals are accomplished with volume repletion, calcium normalization and removal of the tumor. Effective therapy includes saline infusion and furosemide. Additional control is obtained with phosphates and/or indomethachin. In refractory cases actinomycin-D or mithramycin is helpful. The first reported case of urethral cancer and second reported case of testicular seminoma producing this syndrome are added to the literature.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566330     DOI: 10.1016/s0022-5347(17)57596-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Elevated parathyroid hormone-related peptide in a patient with an extragonadal germ-cell tumour and hypercalcemia.

Authors:  Steven Sorscher
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

Review 2.  [Hypocalcemia in malignant diseases].

Authors:  E Heidbreder; K Schafferhans; A Heidland
Journal:  Klin Wochenschr       Date:  1983-08-15

3.  1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.

Authors:  René Rodríguez-Gutiérrez; Maria Azucena Zapata-Rivera; Dania Lizeth Quintanilla-Flores; Carlos Rodrigo Camara-Lemarroy; Fernando Javier Lavalle-Gonzalez; José Gerardo González-González; Jesús Zacarías Villarreal-Pérez
Journal:  BMC Endocr Disord       Date:  2014-04-10       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.